RESISTANCE (R) AND CROSS-RESISTANCE (XR) OF HUMAN OVARIAN-CANCER (OC) CELL-LINES TO ADRIAMYCIN (AD), MELPHALAN (ME) AND IRRADIATION (XRT)

被引：0
|
作者：
BEHRENS, BC [1 ]
LOUIE, KG [1 ]
HAMILTON, TC [1 ]
CURT, G [1 ]
KINSELLA, T [1 ]
YOUNG, RC [1 ]
OZOLS, RF [1 ]
机构：
[1] NCI,DIV CANC TREATMENT,BETHESDA,MD 20205
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1984年 / 25卷 / MAR期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：336 / 336
页数：1
相关论文
共 50 条
  • [1] CROSS-RESISTANCE TO DIVERSE DRUGS IS ASSOCIATED WITH PRIMARY CISPLATIN RESISTANCE IN OVARIAN-CANCER CELL-LINES
    HAMAGUCHI, K
    GODWIN, AK
    YAKUSHIJI, M
    ODWYER, PJ
    OZOLS, RF
    HAMILTON, TC
    [J]. CANCER RESEARCH, 1993, 53 (21) : 5225 - 5232
  • [2] INCREASED DNA-REPAIR IN HUMAN OVARIAN-CANCER (OC) CELL-LINES (CL) WITH INDUCED RESISTANCE (R) TO CISPLATIN (P) OR MELPHALAN (M)
    MASUDA, H
    HAMILTON, TC
    YOUNG, RC
    OZOLS, RF
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1986, 27 : 264 - 264
  • [3] CROSS-RESISTANCE TO TUMOR PROMOTERS IN HUMAN CANCER CELL-LINES RESISTANT TO ADRIAMYCIN OR CISPLATIN
    NISHIO, K
    SUGIMOTO, Y
    NAKAGAWA, K
    NIIMI, S
    FUJIWARA, Y
    BUNGO, M
    KASAHARA, K
    FUJIKI, H
    SAIJO, N
    [J]. BRITISH JOURNAL OF CANCER, 1990, 62 (03) : 415 - 419
  • [4] VERAPAMIL (V) PLUS ADRIAMYCIN (ADR) IN REFRACTORY OVARIAN-CANCER (OC) - DESIGN OF A CLINICAL-TRIAL ON BASIS OF REVERSAL OF ADR RESISTANCE (R) IN HUMAN OC CELL-LINES (CL)
    OZOLS, RF
    ROGAN, AM
    HAMILTON, TC
    KLECKER, R
    YOUNG, RC
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 300 - 300
  • [5] AUGMENTATION OF ADRIAMYCIN (AD), MELPHALAN (ME), AND CISPLATIN (CP) CYTO-TOXICITY (CT) BY BUTHIONINE SULFOXIMINE DEPLETION OF GLUTATHIONE (GSH) IN DRUG (D) RESISTANT (R) HUMAN OVARIAN-CANCER (OC) CELL-LINES (CL)
    HAMILTON, TC
    WINKER, MA
    LOUIE, KG
    BATIST, G
    FINE, RL
    BEHRENS, BC
    TSURUO, T
    GROTZINGER, KR
    MCKOY, WM
    YOUNG, RC
    OZOLS, RF
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1985, 26 (MAR): : 345 - 345
  • [6] RESISTANCE TO CISPLATINUM AND PATTERNS OF CROSS-RESISTANCE IN 2 AUTOLOGOUS HUMAN OVARIAN ADENOCARCINOMA CELL-LINES
    HAYWARD, IP
    LAWRIE, SS
    LAUDONIO, ARR
    MCDONALD, A
    SMYTH, JF
    [J]. BRITISH JOURNAL OF CANCER, 1986, 54 (01) : 185 - 185
  • [7] MITOMYCIN-C CROSS-RESISTANCE INDUCED BY ADRIAMYCIN IN HUMAN OVARIAN-CANCER CELLS-INVITRO
    MIZUNO, K
    FURUHASHI, Y
    MAEDA, O
    IWATA, M
    MISAWA, T
    KAWAI, M
    KANO, T
    TOMODA, Y
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1990, 26 (05) : 333 - 339
  • [8] INVITRO CROSS-RESISTANCE PATTERNS OF ANTHRACYCLINES IN HUMAN NON-SMALL CELL LUNG-CANCER CELL-LINES WITH DIFFERING INHERENT RESISTANCE TO ADRIAMYCIN
    MERRY, S
    COURTNEY, ER
    MCCORMICK, C
    KAYE, SB
    FRESHNEY, RI
    [J]. BRITISH JOURNAL OF CANCER, 1987, 55 (03) : 336 - 337
  • [9] MELPHALAN (ME) RESISTANCE (R) IN HUMAN OVARIAN-CANCER (OC) - POTENTIATION OF ME CYTO-TOXICITY BY NUTRITIONAL AND PHARMACOLOGIC DEPLETION OF INTRACELLULAR GLUTATHIONE (GSH) LEVELS
    GREEN, JA
    VISTICA, DT
    YOUNG, RC
    HAMILTON, TC
    ROGAN, AM
    OZOLS, RF
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 290 - 290
  • [10] ADRIAMYCIN ACCUMULATION AND METABOLISM IN ADRIAMYCIN-SENSITIVE AND ADRIAMYCIN-RESISTANT HUMAN OVARIAN-CANCER CELL-LINES
    LOUIE, KG
    HAMILTON, TC
    WINKER, MA
    BEHRENS, BC
    TSURUO, T
    KLECKER, RW
    MCKOY, WM
    GROTZINGER, KR
    MYERS, CE
    YOUNG, RC
    OZOLS, RF
    [J]. BIOCHEMICAL PHARMACOLOGY, 1986, 35 (03) : 467 - 472
12345